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296The composite of cardiovascular events, stroke,
and MI in the HZ group was higher than in the non-HZ
group (Table 1). The differences of absolute in-
cidences for stroke and MI in HZ group when
compared to non-HZ group were 1.34 per 1,000
person-years (95% confidence intervals [CI]: 0.71 to
1.97) and 0.80 per 1,000 person-years (95% CI: 0.41 to
1.18), respectively. The hazard ratios for stroke were
highest in the subgroup under 40 years of age, a
relatively younger population with fewer risk factors
for atherosclerosis, and gradually decreased with age.
Regarding temporal relationship, the risks of both
stroke and MI were highest in the first year after the
onset of HZ and then tended to decrease with time,
whereas it was evenly distributed in the non-HZ
group (data not shown).
The association of varicella-zoster virus (VZV)
with stroke and MI is reminiscent of previous
“infection hypotheses” such as the association be-
tween chlamydia infection and atherosclerosis,
which was eventually rejected by the WIZARD
(Weekly Intervention With Zithromax for Athero-
sclerosis and Its Related Disorders) study demon-
strating that antibiotics against C. pneumoniae failed
to improve outcomes in coronary artery diseases (2).
This skeptical position with regard to the association
of chlamydia with atherosclerosis should not be
directly applied to the association of VZV with stroke
and MI. VZV is the only virus for which there is clear
evidence of viral DNA and antigen in areas of
ischemia or infarction in cerebral arteries (3). More-
over, the diagnosis of HZ such as the presence of VZV
in the saliva of patients with HZ is more direct than
that of chlamydia infection, which was largely based
on serology. There are several possible biological
causes of stroke and MI after HZ: 1) VZV replication
adjacent to an artery, which leads to inflammation of
the artery and subsequent thrombosis and rupture;
2) repeated subclinical reactivation of VZV and a
subsequent effect on the arteries; 3) transaxonal
migration of VZV in a centripetal direction; 4)
increased sympathetic tone, blood pressure, and
adverse emotional reactions; and 5) the altered
immunological status caused by VZV reactivation
and subsequent vulnerability to cerebrovascular
events.
In conclusion, we have demonstrated that HZ
significantly increases the risk of stroke and MI even
after rigorously adjusting possible confounding
factors in a large population cohort. In propensity
score-matched analysis, HZ raised the risks of the
composite of cardiovascular events, stroke, and MI by
41%, 35%, and 59%, respectively. The risks wereespecially high in the relatively young who have
fewer risk factors for atherosclerosis. Furthermore,
there was a substantial temporal link between HZ and
the occurrence of stroke and MI.Min-Chul Kim, MD
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Target 2010;10:105–11.Are T-Inversions in Chest
Leads Always Benign?We read with great interest the paper by Malhotra
et al. (1) who investigated the prevalence and signif-
icance of anterior T-wave inversions in young white
adults. They reported that anterior T-wave inversions
were present in 2.3% of the study population (of
whom 20% were athletes), but T-wave inversions
extended beyond lead V2 in only 0.5% (0.2% of men;
1.2% of women). Although anterior T-wave inversions
represent a major criterion in the diagnosis of
arrhythmogenic right ventricular cardiomyopathy
(ARVC) (2), none of the participants fulfilled the
J A C C V O L . 7 0 , N O . 2 , 2 0 1 7 Letters
J U L Y 1 1 , 2 0 1 7 : 2 9 3 – 3 0 0
297diagnostic criteria for ARVC after further evaluation
or experienced adverse events during the 2-year
follow-up.
These findings by Malhotra et al. (1) extend the
previous observations on the benign clinical course of
anterior T-wave inversions in young adults and ath-
letes. However, contrary to what the investigators
state in their paper, the prevalence and prognostic
significance of T-wave inversions in right precordial
leads V1 to V3 have been previously reported in white
adults in >10,000 Finnish middle-aged subjects from
the general population (3). In the Finnish study, the
prevalence of anterior T-wave inversions was also
0.5%, with a surprisingly similar distribution between
men (0.1%) and women (0.9%) as Malhotra et al. (1)
reported. T-wave inversions normalized during the
course of the study in only 20% of the subjects. During
the mean follow-up of 30 years, no increase in mor-
tality was observed among those with anterior T-wave
inversions. In contrast, T-wave inversions beyond
leads V1 to V3 were associated with increased risk of
mortality and sudden cardiac death. Therefore, it
should be emphasized that all T-wave inversions in
chest leads may not be benign, even in young athletes.
Together, these data will help to reassure subjects
with isolated anterior T-wave inversions about the
benign nature of this finding. However, decisions
about the need for further evaluation of patients with
this electrocardiographic pattern need to be individ-
ualized based on the extent of T-wave inversions and
other electrocardiographic and clinical features, as
well as the estimated prevalence of ARVC in the
specific geographic region.*Aapo L. Aro, MD, PhD
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Always Benign?We are grateful to Dr. Aro and colleagues for their
interest in our paper (1). They cite their study of
10,899 middle-aged subjects, including 52% of males,
that investigated the presence of anterior T-wave
inversion over a substantial mean follow-up of 30 
11 years (2). The prevalence of T-wave inversion in
leads V1 to V3 was 0.5% and similar to that reported in
our study. There was no increase in mortality among
this group, contrary to T-wave inversion in leads
other than leads V1 to V3, which was associated with
an increased risk of cardiac and arrhythmic death.
This study supports our findings that T-wave inver-
sion in the anterior leads may be a physiological
variant among white individuals in the absence of
symptoms or a concerning family history. Both
studies suggest that electrocardiographic criteria
used by the Task Force recommendations for
arrhythmogenic right ventricular cardiomyopathy
(ARVC) may be nonspecific in the general population
(3). However, we did emphasize that the benign
pattern pertained to T-wave inversion limited to
leads V1 to V2, and that extension beyond this may
warrant further investigation. We entirely agree that
T-wave inversion in territories other than an anterior
territory should be investigated further, particularly
as these may be harbingers of cardiomyopathy (4).
We would like to highlight that our study included
14,646 young white athletes and nonathletes, aged
between 16 and 35 years. The mean age of these
subjects was 21.7  5.4 years, which was significantly
lower than the middle-aged Finnish subjects (mean
age: 44.0  8.5 years). It is important to note that a
similar prevalence of anterior T-wave inversion
seems to persist among individuals in the third to
fifth decades. However, we do maintain that the rar-
ity of T-wave inversion beyond lead V2, especially in
men (<0.3%), warrants further investigation. This is
particularly relevant to the electrocardiograms of
young athletes in light of recent studies that have
suggested that exercise increases age-related pene-
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